Welcome to our dedicated page for Cardinal Health SEC filings (Ticker: CAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cardinal Health, Inc. filings document material events for a healthcare distribution and medical products company, including quarterly results, Regulation FD outlook updates and earnings presentation exhibits. The records tie financial reporting to segment performance, capital returns, debt reduction and corporate finance matters such as revolving credit agreements that support the commercial paper program.
Governance filings cover board composition, annual meeting voting results, director and officer transitions, and related compensation or succession disclosures. The company’s 8-K record also includes material definitive agreements, shareholder voting matters, financial covenants, exhibits and other capital-structure disclosures for Cardinal Health’s public-company profile.
Cardinal Health, Inc. submitted a Form 144 notice indicating a proposed sale of 2,746 common shares with a filing date of 02/27/2026. The disclosure lists restricted stock vesting events of 1,973 shares on 08/15/2024 and 773 shares on 03/15/2024.
Cardinal Health Chief Financial Officer Aaron E. Alt reported two recent transactions in the company’s common shares. On February 18, 2026, he completed an open-market sale of 2,328 shares at an average price of $225.50 per share. On February 15, 2026, 1,914 shares were disposed of to cover tax withholding obligations tied to the vesting of 4,242 restricted share units, using a price of $220.79 per share that reflects the prior business day’s close. After these transactions, Alt directly owns 26,408 common shares of Cardinal Health.
Cardinal Health director Patricia Hemingway Hall reported a sale of company stock. On 02/06/2026, she sold 4,000 Common Shares of Cardinal Health at a price of $229.72 per share. After this transaction, she directly holds 28,264 Cardinal Health common shares.
Cardinal Health received a notice of proposed sale under Rule 144 for its common stock. A holder who acquired shares as board compensation on 11/06/2019 and 11/04/2020 plans to sell 4,000 common shares through Merrill Lynch on the NYSE around 02/06/2026, with an aggregate market value of 918,760. Cardinal Health had 235,316,016 common shares outstanding at the time referenced in the notice.
Cardinal Health delivered strong growth for the quarter ended December 31, 2025. Revenue rose 19% to $65.6 billion, driven mainly by branded and specialty pharmaceuticals, while six-month revenue increased 21% to $129.6 billion. GAAP operating earnings grew 29% to $707 million and non-GAAP operating earnings were up 38% to $877 million.
GAAP diluted EPS increased 19% to $1.97, with non-GAAP diluted EPS up 36% to $2.63, reflecting contributions from recent acquisitions and stronger pharma and generics performance, partly offset by higher interest expense. The company completed the $1.9 billion Solaris Health acquisition, continued integrating other MSO platforms, repurchased $758 million of shares, paid $251 million in dividends, and ended the quarter with $2.8 billion in cash and $9.0 billion of long-term obligations while carrying $4.3 billion in opioid-related accruals.
Cardinal Health, Inc. reported that it has released its financial results for the quarter ended December 31, 2025, via a news release furnished as Exhibit 99.1. These second-quarter results cover the company’s performance midway through its fiscal year.
The Chief Executive Officer and Chief Financial Officer are scheduled to host a webcast at 8:30 a.m. Eastern time on February 5, 2026 to discuss the quarterly results and the outlook for the fiscal year ending June 30, 2026. A slide presentation and an audio replay of the webcast will be available on the Investors page at ir.cardinalhealth.com.
BlackRock Portfolio Management LLC has filed an amended Schedule 13G reporting its beneficial ownership in Cardinal Health, Inc. common stock. As of the event date, it beneficially owned 9,141,796 shares, representing 3.8% of the outstanding common stock. The firm has sole voting power over 8,465,682 shares and sole dispositive power over 9,141,796 shares, with no shared voting or dispositive power reported.
The filing states that various persons have rights to receive dividends or sale proceeds from these shares, but no single person has more than five percent of the total outstanding common shares of Cardinal Health. BlackRock Portfolio Management LLC certifies that the shares were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of Cardinal Health.
Cardinal Health Chief Human Resources Officer receives equity grant
Cardinal Health’s Chief Human Resources Officer, Valerie Christine Pitteroff, acquired 3,982 common shares on January 15, 2026, reported as an acquisition at a reference price of $213.26 per share. The footnotes explain this is a grant of restricted share units that will vest in three equal annual installments beginning on August 15, 2027, meaning the shares are subject to time-based vesting conditions.
After this grant, she beneficially owns 8,022 common shares directly and 463 common shares indirectly through a 401(k) plan. The filing does not report any sales of Cardinal Health stock, only this new award and updated beneficial ownership totals.
Cardinal Health, Inc. reported that it has updated its previously issued fiscal year 2026 non-GAAP earnings per share outlook. This means the company has revised its internal expectations for how much profit per share it plans to generate, after adjusting for certain items.
The company also highlighted its upcoming appearance at the 44th Annual J.P. Morgan Healthcare Conference, scheduled for January 13 at 9:00 a.m. Pacific Standard Time. Additional details are provided in a news release issued on January 13, 2026 and attached as an exhibit.